What is the diagnosis and recommended treatment for Haemophilus influenzae infection?

Haemophilus influenzae: Diagnosis and Treatment

Diagnosis

Haemophilus influenzae infection is confirmed through microbiologic studies including cultures of blood, cerebrospinal fluid (CSF), and other normally sterile fluids, with Gram staining of specimens providing rapid provisional diagnosis. 1

Key Diagnostic Approaches:

• Culture remains the gold standard: Blood, CSF, and other sterile fluid cultures are diagnostic and mandatory when invasive disease is suspected 1
• Gram staining: Should be performed on all specimens obtained for culture to provide rapid preliminary information 1
• Capsular antigen detection: Immunoelectrophoresis, latex agglutination, or enzyme-linked immunosorbent assay can detect capsular antigen in serum, CSF, or concentrated urine in up to 90% of culture-proven meningitis cases 1
• Molecular methods: PCR assays can detect H. influenzae directly from CSF, particularly valuable in culture-negative cases or when prior antibiotics have been administered 2

Clinical Presentations to Recognize:

• Invasive infections (predominantly type b strains in children): Meningitis, septic arthritis, epiglottitis, facial cellulitis, bacteremia 1
• Respiratory tract infections (usually nontypeable strains): Otitis media, sinusitis, pneumonia, bronchitis 1, 3

Treatment

For Meningitis (Invasive Disease)

For confirmed H. influenzae meningitis, treat with ceftriaxone 2 g IV every 12 hours OR cefotaxime 2 g IV every 6 hours for 10 days. 4

• Alternative option: Moxifloxacin 400 mg once daily for 10 days 4
• Treatment duration may need extension if the patient is not responding adequately 4
• Third-generation cephalosporins are preferred as initial therapy for life-threatening H. influenzae infection, particularly cefotaxime or ceftriaxone 1

For Respiratory Tract Infections in Adults

For community-acquired pneumonia caused by H. influenzae, use oral co-amoxiclav OR doxycycline as first-line therapy. 5

Non-Severe Pneumonia (Outpatient):

• Preferred: Co-amoxiclav 625 mg three times daily OR doxycycline 200 mg loading dose, then 100 mg once daily for 7 days 5
• Alternative: Macrolide (clarithromycin 500 mg twice daily OR erythromycin 500 mg four times daily) for penicillin-intolerant patients 5

Severe Pneumonia (Inpatient):

• Preferred: IV co-amoxiclav OR second-generation cephalosporin (cefuroxime 1.5 g IV every 8 hours) OR third-generation cephalosporin (cefotaxime 1-2 g IV every 8 hours) 6, 7, 5
• Alternative for β-lactamase positive strains: Levofloxacin 750 mg IV/PO once daily OR moxifloxacin 400 mg IV/PO once daily 7
• Duration: 7-10 days for most cases; extend to 14-21 days if S. aureus or Gram-negative enteric bacilli are suspected 5

For Pediatric Infections

For children under 12 years with H. influenzae respiratory infection, co-amoxiclav is the drug of choice. 5

• Alternative for penicillin allergy: Clarithromycin OR cefuroxime 5
• For children over 12 years: Doxycycline is an alternative option 5
• Inpatient empiric therapy: Ampicillin or penicillin G for fully immunized children in areas with minimal penicillin resistance; ceftriaxone or cefotaxime for incompletely immunized children or areas with significant resistance 8

Critical Considerations

Ampicillin Resistance

Ampicillin resistance due to β-lactamase production has increased significantly, reaching 16.4% overall and 19% in recent years (2011-2014). 9

• All H. influenzae isolates should be tested for β-lactamase production to guide therapy 10
• Empiric therapy should account for local resistance patterns: In communities with high ampicillin resistance rates (18-22% nationally), avoid ampicillin as empiric monotherapy for serious infections 10
• β-lactamase-negative, ampicillin-resistant (BLNAR) strains with PBP3 mutations account for 14.6% of isolates 9

Antibiotic Administration Timing

Antibiotics must be administered within 4 hours of hospital admission for pneumonia, as delays are associated with increased mortality. 6

Switching to Oral Therapy

Patients initially treated with parenteral antibiotics should be switched to oral regimens once clinical improvement occurs and temperature has been normal for 24 hours. 5

Chemoprophylaxis for Contacts

When H. influenzae type b is confirmed, the index case and all household contacts in households containing at-risk individuals should receive rifampicin 20 mg/kg (maximum 600 mg) once daily for 4 days. 4

• At-risk individuals include: Children under 10 years or immunosuppressed persons of any age 4
• Vaccination: All previously unvaccinated household contacts under age 10 should receive Hib vaccination 4

Common Pitfalls to Avoid

• Do not rely solely on ampicillin for empiric treatment of serious H. influenzae infections given rising resistance rates 10, 9
• Do not delay antibiotic administration in hospitalized patients with suspected bacterial pneumonia 6
• Do not use chloramphenicol as monotherapy for meningitis without considering local resistance patterns and multidrug resistance 2
• Do not forget supportive care: Antibiotic therapy is only one component; critical attention to supportive measures is essential 1